{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-033119","form_type":"8-K","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2024-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.775026+00:00","generated_at":"2026-05-31T08:45:16.070223+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Eterna Therapeutics sets 2024 annual meeting for Sept 27; proposal deadline Aug 29","bullets":["Annual meeting scheduled for September 27, 2024.","Stockholder proposals and nominations must be received by August 29, 2024.","Date is >30 days from 2023 annual meeting anniversary, triggering special notice timeline.","All notices must be directed to company's principal executive offices per bylaws."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-033119","json":"https://secwatch.observer/filing/0001493152-24-033119.json","markdown":"https://secwatch.observer/filing/0001493152-24-033119.md","text":"https://secwatch.observer/filing/0001493152-24-033119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000149315224033119/0001493152-24-033119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000149315224033119/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:45:16.070223+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001104659-26-069516","ticker":"ESOA","company_name":"Energy Services of America CORP","filed_at":"2026-06-02T20:30:59+00:00","headline":"Energy Services of America to present at East Coast IDEAS Investor Conference on June 11, 2026","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.1,"calibrated_materiality_score":0.1,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069516","json":"https://secwatch.observer/filing/0001104659-26-069516.json","markdown":"https://secwatch.observer/filing/0001104659-26-069516.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357971/000110465926069516/0001104659-26-069516-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357971/000110465926069516/tm2616596d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063549","ticker":"IMAQ","company_name":"International Media Acquisition Corp.","filed_at":"2026-06-01T20:45:22+00:00","headline":"International Media Acquisition extends business combination deadline to July 2, 2026","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.25,"calibrated_materiality_score":0.25,"match_reasons":["same SEC item: 8.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063549","json":"https://secwatch.observer/filing/0001213900-26-063549.json","markdown":"https://secwatch.observer/filing/0001213900-26-063549.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1846235/000121390026063549/0001213900-26-063549-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1846235/000121390026063549/ea0292707-8k_inter.htm"},"side_by_side_evidence":null},{"accession":"0001437749-26-019196","ticker":"NRXP","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2026-06-02T21:30:08+00:00","headline":"NRx Pharmaceuticals proposes public offering of common stock; terms not set","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-019196","json":"https://secwatch.observer/filing/0001437749-26-019196.json","markdown":"https://secwatch.observer/filing/0001437749-26-019196.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/0001437749-26-019196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/nrxp20260602_8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-253897","ticker":"XMTR","company_name":"Xometry, Inc.","filed_at":"2026-06-02T21:26:17+00:00","headline":"Xometry announces public offering of 2.65M shares at $85.00; expected net proceeds $215.2M","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253897","json":"https://secwatch.observer/filing/0001193125-26-253897.json","markdown":"https://secwatch.observer/filing/0001193125-26-253897.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1657573/000119312526253897/0001193125-26-253897-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1657573/000119312526253897/d109952d8k.htm"},"side_by_side_evidence":null},{"accession":"0001398344-26-010206","ticker":null,"company_name":"Partners Group Lending Fund, LLC","filed_at":"2026-06-02T21:12:15+00:00","headline":"Partners Group Lending Fund reports April 30 NAV of $1.5013/unit; portfolio $501.1M","event_type":"other_material","sec_items":["3.02","8.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 8.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001398344-26-010206","json":"https://secwatch.observer/filing/0001398344-26-010206.json","markdown":"https://secwatch.observer/filing/0001398344-26-010206.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938649/000139834426010206/0001398344-26-010206-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938649/000139834426010206/fp0099279-1_8kixbrl.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-064277","ticker":"TOPP","company_name":"Toppoint Holdings Inc.","filed_at":"2026-06-02T21:10:16+00:00","headline":"Topppoint issues statement at NYSE request; no undisclosed material developments behind unusual trading","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same SEC item: 8.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-064277","json":"https://secwatch.observer/filing/0001213900-26-064277.json","markdown":"https://secwatch.observer/filing/0001213900-26-064277.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1960847/000121390026064277/0001213900-26-064277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1960847/000121390026064277/ea0293039-8k_toppoint.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-253795","ticker":"AVA","company_name":"AVISTA CORP","filed_at":"2026-06-02T21:02:55+00:00","headline":"Avista signs non-binding MOU for 125 MW load, expandable to 500 MW by 2032","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 8.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253795","json":"https://secwatch.observer/filing/0001193125-26-253795.json","markdown":"https://secwatch.observer/filing/0001193125-26-253795.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/104918/000119312526253795/0001193125-26-253795-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/104918/000119312526253795/ava-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-039818","ticker":"ARVN","company_name":"ARVINAS, INC.","filed_at":"2026-06-02T20:39:40+00:00","headline":"Arvinas to out-license ARV-806 after completing Phase 1 dose escalation","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 8.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039818","json":"https://secwatch.observer/filing/0001628280-26-039818.json","markdown":"https://secwatch.observer/filing/0001628280-26-039818.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026039818/0001628280-26-039818-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026039818/arvn-20260602.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}